Calculating the dose count of a peptide vial lets you plan your supply accurately, estimate cost per dose, and avoid running out mid-protocol. The answer depends on two variables: the total content of the vial in milligrams, and the dose size per injection. This page walks through the formula and common scenarios.
The core calculation is a single division. Convert all values to the same unit (milligrams) before dividing.
Example 1: A 10 mg tirzepatide vial, dosing at 2.5 mg per injection. 10 ÷ 2.5 = 4 doses.
Example 2: A 5 mg BPC-157 vial, dosing at 250 mcg (0.25 mg) per injection. 5 ÷ 0.25 = 20 doses.
To calculate how long a vial lasts, divide the total doses by your injection frequency per week. 20 doses at twice daily (14 injections/week) = about 1.4 weeks of supply.
Common vial sizes and dose sizes across GLP-1 peptides and research peptides like BPC-157 and TB-500.
| Vial Size | Dose/Injection | Total Doses | Weekly (1x/wk) |
|---|---|---|---|
| 5 mg | 250 mcg (0.25 mg) | 20 doses | 20 weeks |
| 5 mg | 500 mcg (0.5 mg) | 10 doses | 10 weeks |
| 5 mg | 0.25 mg/week | 20 doses | 20 weeks |
| 10 mg | 2.5 mg | 4 doses | 4 weeks |
| 10 mg | 5 mg | 2 doses | 2 weeks |
| 15 mg | 2.5 mg | 6 doses | 6 weeks |
| 15 mg | 5 mg | 3 doses | 3 weeks |
Dead volume matters. Most insulin syringes have 0.02–0.05 mL of dead space in the needle hub. At high concentrations, this represents a non-trivial amount of peptide left in the needle after injection. If precision matters, use syringes with integrated (fixed) needles to minimize dead space.
Reconstitution volume also affects your dose count planning. If you add more water than expected (or lose some water volume during needle insertion), your actual concentration will differ slightly from your target. ASCEND's calculator accounts for your exact water volume to give accurate draw-to-unit values.